The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL

British Journal of Haematology

Volumn 92, Issue 1, 1996, Pages 104-115

  Chim, James C S ^a,b   Coyle, Luke A ^a   Yaxley, John C ^a   Cole Sinclair, Merrole F ^a,c   Cannell, Paul K ^a,d   Hoffbrand, Victor A ^a   Foroni, Letizia ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Alfred Group of Hospitals   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

Author keywords

ALL; ASO tests; Fingerprinting; MRD

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; DNA FINGERPRINTING; HUMAN; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030040436     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.289831.x     Document Type: Article

References (38)

1. Beishuizen, A., Hahlen, K., Hagemeijr, H., Verhoeven, M.J., Hooijkaas, H., Andriaansen, H.J., Wolvers-Tettero, I.L.M., van Wering, E.R. & van Dongen, J.J.M. (1991) Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia, 5, 657-667.
2. Berman, J.E., Melli., S.J., Pollock, R., Smith, C.L., Suh, H., Heinke, B., Kowal, C., Surti, U., Chess, L., Cantor, C.R. & Alt, F.W. (1988) Content and organisation of the human IgH VH locus: definition of three new VH families and linkage to the γ CH locus. EMBO Journal, 7, 727-738.
3. Billadeau, D., Blackstadt, M., Greipp, P., Kyle, R.A., Oken, M.M., Kay, N. & Van Ness, B. (1991) Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantification of residual disease. Blood, 78, 3021-5029.
4. Biondi, A., Yokota, T. & Hansen-Hagge, T. (1992) Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia, 6, 282-288.
5. Brisco, J.M., Condon, J., Hughes, E., Neoh, S.H., Sykes, P.J., Williams, R., Seshadri, R., Toogood, I., Waters, K., Tauro, G., Ekert, H. & Morley, A.A. (1994) Prediction of outcome in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet, 344, 196-200.
6. Brisco, M., Tan, L. Osborn, A. & Morley, A. (1990) Development of a highly sensitive assay, based on the polymerase chain reaction for rare B-lymphocyte clones in a polyclonal population. British Journal of Haematology, 75, 163-167.
7. Buluwela, L., Albertson, D.G., Sherrington, P., Rabbitts, P., Spurr, N. & Rabbitts, T.H. (1988) The use of chromosomal translocation to study the human immunoglobulin gene organisation: mapping DH segments within 35 kb of the Cm gene and identification of a new DH locus. EMBO Journal, 7, 2003-2010.
8. Cole-Sinclair, M., Foroni, L. & Hoffbrand, A.V. (1994) Acute lymphoblastic leukaemia. Bailliere's International Practice and Research: Clinical Haematology, 7, 183-233.
9. Cole-Sinclair, M.F., Foroni, L., Wright, F., Mehta, A.B., Prentice, H.G. & Hoffbrand, A.V. (1993) Minimal residual disease in acute lymphoblastic leukaemia: PCR analysis of immunoglobin gene rearrangements. Leukaemia and Lymphoma, 11, (Suppl. 2), 49-58.
10. Colin, G., Steward, C. Potter, M.N. & Oakhill, A. (1992) Third complementarity region (CDRIII) sequence analysis in childhood lineage acute lymphoblastic leukemia: implications for the design of oligonucleotide probes for monitoring minimal residual disease. Leukemia, 6, 1213-1219.
11. Deane, M. & Hoffbrand, A.V. (1993) Detection of minimal residual disease in acute lymphoblastic leukaemia. Leukemia: Advances Research and Treatment (ed. by E. J. Freireich and H. Kantarjian), Vol. 8, pp. 1 35-140. Kluwer Academic Publishers, Dordrecht.
12. Deane, M. & Norton, N. (1990) Immunoglobulin heavy chain variable region family usage is independent of tumour cell phenotype in human B lineage leukaemias. European Journal of Immunology, 20, 2209-2217.
13. Deane, M. & Norton, J. (1991) Immunoglobulin gene 'finger-printing': an approach to analysis of B lymphoid clonality in lymphoproliferative disorders. British Journal of Haematology, 77, 274-281.
14. Deane, M., Pappas, H. & Norton, J.D. (1991) Immunoglobulin heavy chain gene fingerprinting reveals widespread oligoclonality in B-lineage acute lymphoblastic leukemia. Leukemia, 5, 832-838.
15. Foroni, L., Mason, P.J. & Luzzatto, L. (1991) Ig and T cell receptor gene rearrangements. The Leukaemic Cell: Methods in Haematology (ed. by D. Catovsky), Chapter XIII, pp. 339-591. Churchill Livingstone, Edinburgh.
16. Hagenbeek, A. (1992) Minimal residual disease in leukaemia: state of the art 1991. Leukemia, 6, (Suppl. 2), 12-16.
17. Ichihara, Y., Matsuoka, H. & Kurosawa, Y. (1988) Organisation of the human immunoglobulin heavy chain gene loci. EMBO Journal 7, 4141-4150.
18. Ito, Y., Wasserman, R., Galili, N., Reichard, B.A., Shane, S., Lange, B. & Rovera, G. (1993) Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia. Journal of Clinical Oncology, 11, 546-553.
19. Jonsson, O., Kitchens, R., Scott, F. & Smith, R. (1990) Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood, 76, 2072-2079.
20. Katz, F., Ball, L., Gibbons, B. & Chessels, J. (1989) The use of DNA probes to monitor minimal residual disease in childhood acute leukaemia. British Journal of Haematology, 73, 173-180.
21. Kitchingman, G.R., Mirro, J., Stass, S., Rovigatti, U., Melvin, S.L., Williams, D., Raimondi, S. & Murphy, S.B. (1986) Biologic and prognostic significance of the presence of more than two μ heavy-chain genes in childhood acute lymphoblastic leukemia of B precursor cell origin. Blood, 67, 698-703.
22. Langlands, K., Gouldon, N.J., Steward, C.G., Potter, M.N., Cornish, J.M., Pamphilon, D.H. & Oakill, A. (1994) False positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. (Letter). Blood, 84, 1352-1353.
23. MacIntyre, E., d'Auriol, L., Duparc, G., Leverger, G., Galibert, F. & Sigaux, F. (1990) Use of oligonucleotide probes directed against the T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias. Journal of Clinical Investigation, 86, 2125-2135.
24. Matsuda, F., Shin, E.K., Hirbayashi, Y., Nagaoka, H., Yoshida, M.C., Zong, S.Q. & Honjio, T. (1990) Organisation of the human immunoglobulin heavy chain: duplication of the D5 cluster within the locus and inter chromosomal translocation of variable region segments. EMBO Journal, 8, 2501-2506.
25. Neale, G., Menarguezm, J., Kitchingman, G., Fitzgerald, T.J., Koeehler, M., Mirro, J., Jr & Goorha, R.M. (1991) Detection of minimal residual disease in T-cell lymphoblastic leukemia using polymerase chain reaction predicts impending relapse. Blood, 78, 739-747.
26. Porfiri, E., Seeker-Walker, L.M., Hoffbrand, A.V. & Hancock, J.F. (1993) DCC tumour suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood, 81, 2696-2701.
27. Potter, M., Cross, N., van Dongen, J.M., Saglio, G., Oakill, A., Bartram, C.C.R. & Goldman, J.M. (1993a) Molecular evidence of minimal residual disease after treatment for leukemia and lymphoma: reports of the Fourth Workshop of the Molecular Biology/BMT Study Group. Leukemia, 7, 1302-1314.
28. Potter, M., Steward, C., Maitland, N. & Oakhill, A. (1992) Detection of clonality in childhood B-lineage acute lymphoblastic leukemia by polymerase chain reaction. Leukemia, 6, 289-2894.
29. Potter, M.N., Steward, C.G. & Oakhill, A. (1993b) The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. British Journal of Haematology, 83, 412-418.
30. Ravetch, J.V., Siebelist, U., Korsmeyer, S.J., Waldmann, T. & Leder, P. (1981) Structure of the human immunoglobulin μ locus: characterisation of embryonic and rearranged D genes. Cell, 27, 583-591.
31. Rovera, G., Wasserman, R. & Yamada, M. (1991) Detection of minimal residual disease in childhood leukemia by the polymerase chain reaction. (Letter). New England Journal of Medicine, 324, 774.
32. Sonntang, D., Weingartner, B. & Grutzamann, R.A. (1989) A member of a novel human DH gene family: DHFL16. Nucleic Acids Research, 17, 1267.
33. Steward, C.G., Gouldon, N.J., Katz, F., Martin, P.G., Langlands, K., Potter, M.N., Chessel, J.M. & Oakhill, A.A. (1994) PCR study of the stability of IgH heavy chain and T cell receptor δ gene rearrangements between presentation and relapse of childhood B lineage acute lymphoblastic leukemia. Blood, 83, 1355-1362.
34. Steward, C., Potter, M. & Oakhill, A. (1992) Third complementarity determining region (CDR-III) sequence analysis in childhood B-lineage acute lymphoblastic leukemia: implications for the design of oligonucleotides for use in monitoring minimal residual disease. Leukemia, 6, 1213-1219.
35. Walter, M.A., Surti, U., Hofker, M.H. & Cox, D.W. (1990) The physical organisation of the human immunoglobulin heavy chain gene complex. EMBO Journal, 9, 3303-3313.
36. Wasserman, R., Yamada, M., Ito, Y., Finger, R.L., Reichard, A.B., Shane, S., Lange, B. & Rovera, G. (1992) VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood, 79, 223-228.
37. Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S.S., Lange, B., Tsujimoto, Y., Canton, A.J. & Rovera, G. (1989) Detection of minimal disease in hematopoietic malignancies of B-cell lineage by using third-complementarity-determining region (CDR-III)-specitic probes. Proceedings of the National Academy of Sciences of the United States of America, 86, 5123-5127.
38. Yokota, S., Hansen-Hagge, T.E., Ludwig, W.D., Reiter, A., Raghavachar, A., Kleihauer, E. & Bartram, C.R. (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood, 77, 331-339.